CoChat

ERK1/2 Signaling Pathways Involved in VEGF Release in Diabetic Rat Retina

Ye, Xiaofeng, Xu, Gezhi, Chang, Qing, Fan, Jiaweng, Sun, Zhongcui, Qin, Yaowu, Jiang, Alice C. · 2010 · Investigative Opthalmology & Visual Science

The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.

Abstract

PURPOSE: Vascular endothelial growth factor (VEGF) is one of the major factors promoting diabetic retinopathy (DR). A better understanding of the signaling pathway in VEGF regulation is of clinical importance to identify more precise therapeutic targets for diabetic retinopathy. The ERK1/2 signaling pathway has been shown to play a key role in some oncoma and hematologic diseases by mediating VEGF release. This research was conducted to determine whether the ERK1/2 signaling pathway also plays a major role in VEGF release in DR development. METHODS: One hundred Sprague-Dawley (SD) rats were induced to diabetes by streptozotocin (STZ) injection and monitored at several time points (1, 2, 3, 4, 8, and 12 weeks) for ERK1/2 phosphorylation, Activator protein (AP)-1 activity and concentration, and VEGF protein and mRNA expression, using immunohistochemical and biochemical methods. RESULTS. The ERK1/2 signaling pathway was rapidly activated 1 week after diabetes was induced. AP-1, the downstream transcription factor of ERK1/2, was also activated, and VEGF became highly regulated in a similar trend. U0126, an inhibitor of ERK1/2, also downregulated VEGF expression, in addition to ERK1/2 and AP-1 activity. CONCLUSIONS: ERK1/2 signaling pathway is involved in VEGF release in diabetic rat retina; therefore, ERK1/2 may be a potential therapeutic target of DR.

Overview

Integrity signals

Registry

Crossref · 10.1167/iovs.09-4899

Cites

38 of 38 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 38 references

Cited by

See all 47

Metadata

Authors
Ye, X., Xu, G., Chang, Q., Fan, J., Sun, Z., Qin, Y., & Jiang, A. C.
Affiliations
  • From the EENT Hospital, Eye Institute,
  • Fudan University (CN)
  • University of Wisconsin–Madison (US)
Corresponding author
  • Ye, Xiaofeng
  • Xu, Gezhi
  • Chang, Qing
  • Fan, Jiaweng
  • Sun, Zhongcui
  • Qin, Yaowu
  • Jiang, Alice C.
Venue
Investigative Opthalmology & Visual Science
Published
2010-10-01
Volume
51
Issue
10
Pages
5226
ISSN
  • 0146-0404 (ISSN-L)
  • 1552-5783
OpenAlex
W2086454309
Cited by
47
References
38
Citations by year
2026: 4 · 2025: 2 · 2024: 1 · 2023: 3 · 2022: 3 · 2021: 3 · 2020: 3 · 2019: 1 · 2018: 1 · 2017: 7 · 2016: 1 · 2015: 5 · 2013: 6 · 2012: 6
FWCI
4.54
Type
journal article
Language
en
Open access
closed
Locations
  • Investigative Ophthalmology & Visual Science (publishedVersion, public-domain)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Advanced Glycation End Products research
Keywords
ERK signaling, vascular endothelial growth factor, diabetic retinopathy, AP-1 transcription factor, ERK1/2 phosphorylation, U0126, streptozotocin-induced diabetes, VEGF expression regulation, therapeutic target
MeSH terms
Animals, Butadienes, Diabetes Mellitus, Experimental, Diabetic Retinopathy, DNA, Enzyme Inhibitors, Immunoenzyme Techniques, Male, Nitriles, Phosphorylation, RNA, Messenger, Vitreous Body, Blotting, Western, Signal Transduction, Rats, Sprague-Dawley, Transcription Factor AP-1, Mitogen-Activated Protein Kinase 1, Reverse Transcriptase Polymerase Chain Reaction, Electrophoretic Mobility Shift Assay, Vascular Endothelial Growth Factor A, Mitogen-Activated Protein Kinase 3, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.